Call Us: 888-488-5750

Moving the needle on pharmacy benefit management

Recently, VativoRx and CEO Lisa Quarterman were pleased to be highlighted by Healthcare Tech Outlook as a Top Pharmacy Management Solution Provider for 2021.

You can read the full article here, but here’s a preview of what they had to say about VativoRx:

“VativoRx is in a class by itself when it comes to providing innovative PBM services and solutions, thanks to its established industry expertise. The company has been providing pharmacy benefit expertise as a service across the country for more than two decades. With Lisa Quarterman at the helm as the CEO and managing partner, VativoRx is wholly aware of its role and functioning in providing something that could potentially save someone’s life. This motivates the company to perform swiftly and effectively, ensuring no hiccups or lapses occur in their services. The company specializes in the delivery, affordability, and clinical management of prescription medications. The long- established relationships they share with healthcare organizations and third- party administrators enable the company to design and manage PBM programs comprehensively.”

Unlock Hidden Revenue: The Shift to Medical Rebates for Specialty Drugs

Health plans are facing increasing pressure to manage the skyrocketing costs of specialty medications. Specialty drugs, while representing a small fraction of total prescriptions, now account for a substantial share of overall drug spending. As health plans work to balance financial sustainability with member access to high-cost therapies, one growing trend is the increased use of medical-benefit rebates over traditional pharmacy rebates. 

Read More »

VativoRx Joins MHA: A New Chapter Begins

The world of healthcare is dynamic, continuously evolving with new challenges and opportunities. At VativoRx, we’ve always believed in the power of innovation, collaboration, and dedication to ensure that we provide the best rebate management solutions in the industry. Today, we’re thrilled to announce our latest milestone: VativoRx is now an official associate member of the Michigan Health & Hospital Association (MHA)!

Read More »

Unveiling the Future: Navigating the Evolving Landscape of 340B Rebates.

The 340B Drug Pricing Program, established in 1992, has been a crucial component of the healthcare system, dedicated to assisting eligible healthcare organizations in serving vulnerable patient populations by granting them access to discounted drugs. At the heart of this program are the 340B rebates, which enable qualifying entities such as safety-net hospitals, community health centers, and other eligible providers to acquire medications at significantly reduced prices.

Read More »